For research use only. Not for human or veterinary use. Supplied as a lyophilized powder for laboratory research.
Knowing how to read a peptide COA (certificate of analysis) is the fastest way to judge research material before it reaches the bench. A peptide COA is a laboratory’s record of what it measured on one lot. The core results are chromatographic purity (HPLC or UPLC), identity (mass spectrometry), and sometimes quantity and endotoxin. Purity and identity answer different questions, and neither one shows counter-ion content, water content or sterility unless those were tested separately [1][2][3].
Step 1: match the certificate of analysis to the vial
Before reading any number, confirm the COA belongs to the material in hand:
- Lot number: it must match the vial label.
- Compound identifiers: name and, where given, CAS number, molecular formula and molecular weight.
- Testing laboratory, report number and analysis date.
- A validation route: a QR code, a report number searchable on the lab’s site, or a lab contact.
Example from an MFP certificate: the BPC-157 purity COA for lot DPS-9628420 names Horizon Analytical (report no. 1023760, analysis date 08/12/2026), the method (UPLC/MS), formula C₆₂H₉₈N₁₆O₂₂, molecular weight ~1419.5 g/mol and appearance “White Lyophilized Powder”. The formula and weight match PubChem CID 108101.
Step 2: read the HPLC purity result
Reversed-phase HPLC (or the higher-pressure UPLC) separates the components of a sample. The purity figure is normally the main peak’s area as a percentage of total integrated peak area under that method. It is relative and method-dependent: peaks the detector cannot see are not counted [2].
Synthetic peptides have known impurity types that a purity method is meant to resolve [1]:
- Synthesis-related: deletion and insertion sequences, racemization diastereomers, leftover protecting groups, side-chain adducts.
- Degradation-related: oxidation, β-elimination, diketopiperazine, pyroglutamate and succinimide formation.
- Contamination by unrelated peptides, which the review links to poor manufacturing practice.
What to check: the specification next to the result (for example “Specification >98% / Result 99.42%” on lot DPS-9628420), the method named, and the chromatogram where provided. See Peptide Purity Grades Explained.
Step 3: read the mass spec identity result
Mass spectrometry compares the observed mass with the mass expected for the named sequence. LC-MS is also the main tool for characterizing peptide impurities, including isomers and epimers that a single chromatogram can miss [2]. A matching mass supports that the main component is the named peptide; it does not measure how much of it is present. See HPLC vs Mass Spectrometry for Peptides.
Step 4: check quantity and net peptide content
Some certificates report measured quantity against the label claim (lot DPS-9628420: “Specification 10 mg / Result 9.9 mg”). That is a different question from purity. Peptides purified by reversed-phase HPLC are usually isolated as trifluoroacetate (TFA) salts, and counter-ions and residual water add weight without being peptide [3][4]. A 2025 study recommends that counter-ion content be quantified and specified for assays using synthetic peptides [3]. See Net Peptide Content vs HPLC Purity.
Step 5: check the endotoxin result
The bacterial endotoxin test is a pharmacopoeial quality-control method harmonized internationally (ICH Q4B), with the U.S. text in the USP bacterial endotoxins chapter [5]. A peptide COA may report a result such as “<0.05 EU/mL, Pass” (BPC-157 endotoxin certificate, lot DPS-9628420). It is a separate assay; a purity certificate says nothing about endotoxin. See Peptide Endotoxin Testing.
What a peptide COA does not show
Unless a test is listed, assume it was not run. Common gaps: counter-ion and water content [3][4], sterility, full sequence confirmation beyond intact mass [2], and stability after the analysis date.
Peptide COA checklist
| Check | Where to look | Red flag |
|---|---|---|
| Lot match | Lot number on COA vs vial | Missing or different lot |
| Lab and date | Header | No named lab or date |
| Purity method | Purity section | A percentage with no method |
| Identity | MS section | No expected vs observed mass |
| Quantity | Quantity row | Not reported |
| Endotoxin | Separate report or row | Not reported |
| Validation | QR code or report number | No way to verify |
Frequently asked questions
A peptide COA is a certificate of analysis: a laboratory report of tests run on one specific lot, typically HPLC or UPLC purity and mass spectrometry identity [2].
“COA test” usually refers to the set of analyses summarized on the certificate. For research peptides that means purity by chromatography, identity by mass spectrometry, and sometimes quantity and endotoxin [2][5].
No. HPLC purity is a relative peak-area figure under one method. Peptide content also depends on counter-ions such as TFA and on water, which HPLC-UV does not report [3][4].
Match the lot number, confirm the named lab and date, and use the lab’s own lookup where one is offered. See How to Verify a Peptide COA.
Research materials and certificates
- Every published MFP certificate, by product: COA Library
- Research material referenced above: BPC-157
- Related: Third-Party Tested Peptides · Lyophilized Peptide Storage
References
- D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. doi:10.1016/j.jpba.2014.06.012. PMID: 25044089
- Lian Z, Wang N, Tian Y, Huang L. Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives. J Am Soc Mass Spectrom. 2021;32(8):1852-1860. doi:10.1021/jasms.0c00479. PMID: 34110145
- Erckes V, Streuli A, Chamera Rendueles L, Krämer SD, Steuer C. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals (Basel). 2025;18(8):1163. doi:10.3390/ph18081163. PMID: 40872554
- Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277(5):E779-83. doi:10.1152/ajpendo.1999.277.5.E779. PMID: 10567002
- Cai T, Pei Y. The bacterial endotoxin test in the Chinese pharmacopoeia: A journey of international harmonization and national consideration. J Microbiol Methods. 2026;242:107411. doi:10.1016/j.mimet.2026.107411. PMID: 41620123
Research-use-only disclaimer: All products from My Freedom Peptides are supplied as a lyophilized powder for laboratory research. They are for research use only and not for human or veterinary use. My Freedom Peptides LLC is a chemical supplier. It is not a 503A compounding pharmacy or a 503B outsourcing facility. These statements have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease.
